TRAIL

TRAIL

Target · Apoptosis-inducing cytokine

TRAIL TNF superfamily member 10 · Apo-2L

TRAIL (TNF superfamily member 10, also known as Apo-2L, TL2 and CD253) is a cytokine of the tumour necrosis factor family that induces apoptosis by engaging a defined set of TNF receptor superfamily members. It is encoded by the TNFSF10 gene. Browse Assay Genie's current range of TRAIL research reagents below, or read on for the biology behind the target.

Membrane-bound and secretedTNF family cytokineSpares normal cells
281 aa
Protein length
~33 kDa
Molecular weight
3q26.31
Gene locus
TNF family
Protein family
Target information

What is TRAIL (TNF superfamily member 10)?

TRAIL is a cytokine that induces apoptosis. It signals by binding TNFRSF10A/TRAILR1 and TNFRSF10B/TRAILR2, and also binds TNFRSF10C/TRAILR3 and TNFRSF10D/TRAILR4, and possibly TNFRSF11B/OPG. Three of these, TRAILR3, TRAILR4 and OPG, act as decoy receptors that cannot induce apoptosis, so they can modulate TRAIL activity. Engagement of its receptors has been shown to trigger activation of MAPK8/JNK, caspase 8 and caspase 3.

A notable feature of TRAIL biology is its selectivity. The protein preferentially induces apoptosis in transformed and tumour cells, yet does not appear to kill normal cells, even though it is expressed at a significant level in most normal tissues. This makes the TRAIL protein and its receptor system a frequent subject in cell death and cancer research.

The TRAIL gene, TNFSF10, belongs to the tumour necrosis factor ligand superfamily and is listed in the HGNC groups for CD molecules and the TNF superfamily. The protein is found at the cell membrane and in a secreted form. Alternatively spliced transcript variants encoding different isoforms have been described. Aliases include Apo-2L, TL2, CD253 and TANCR, and the gene was previously named tumour necrosis factor (ligand) superfamily, member 10. The mouse ortholog is Tnfsf10.

Apoptosis signalling

TRAIL induces apoptosis through its receptors and triggers activation of caspase 8 and caspase 3, making it a core ligand for studying death receptor pathways.

Cancer cell biology

TRAIL preferentially induces apoptosis in transformed and tumour cells while sparing normal cells, which makes it relevant to studies of tumour cell susceptibility.

Decoy receptor regulation

TRAIL activity may be modulated by binding to TRAILR3, TRAILR4 and OPG, which cannot induce apoptosis, so it is used to examine receptor competition.

JNK and caspase pathways

Receptor binding by TRAIL has been shown to activate MAPK8/JNK as well as caspases, providing a route to study downstream stress signalling.

Background

TRAIL frequently asked questions

What does TRAIL do?

TRAIL is a TNF family cytokine that induces apoptosis. It binds TRAILR1 and TRAILR2, and receptor binding triggers activation of MAPK8/JNK, caspase 8 and caspase 3. It preferentially kills transformed and tumour cells and does not appear to kill normal cells.

What are the other names for TRAIL?

TRAIL is encoded by TNFSF10 (TNF superfamily member 10). Its aliases are Apo-2L, TL2, CD253 and TANCR, and its UniProt name is tumour necrosis factor ligand superfamily member 10. Alternatively spliced transcript variants encoding different isoforms have been found for the gene.

Does TRAIL have decoy receptors, and is it found in mouse?

Yes. TRAILR3, TRAILR4 and OPG can bind TRAIL but cannot induce apoptosis, so they may modulate its activity. The mouse ortholog is Tnfsf10. For any product, check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other TNF superfamily ligands with products at Assay Genie, relevant to cytokine and cell death research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P50591; product specifications from Assay Genie datasheets.

TRAIL Product listing